(ENTA) I don't know the answer, but there are a few possible "facts".
It seemed a little toppy at last earnings report; yet look at the chart from either abbvie or ENTA last earnings; it has just gone up.
At either of those points, at last earnings, I thought the stock could plummet. It didn't, there was a correction of sorts but nothing like we saw in the past. One could make an orderly withdrawal if one wanted. It wasn't by any means a falling knife.
Mavyret is still gaining market share and will likely eclipse the Gilead HCV programs.
It may be that this is behaving more like a known stable stock with room to continue to grow.
(speculation alert- I have to wonder; what will the stock do if ENTA has hit one of the next royalty tiers? Would it suggest a possibility of additional tier this year?... this can also work in reverse as well if no sense of a tier is hit)
Anyone that dumped stock at the last earnings ended up paying gains, and then possibly chasing the stock as it continued to increase in value.
I don't know what will happen today, but this seems to describe the 3 months earlier.
~W
Market Data 
Markets 
AI
